Photodynamic Therapy for Oral Squamous Cell Carcinoma: Current Status, Challenges, and Prospects
Weiqian Zhang1, Shuiying Chen1, Zhongyu Bai1
1Department of Emergency and Oral Medicine, School and Hospital of Stomatology, China Medical University, Liaoning Provincial Key Laboratory of Oral Diseases, Shenyang, Liaoning, People's Republic of China.
International Journal of Nanomedicine
|October 28, 2024
Summary
Photodynamic therapy (PDT) offers a minimally invasive treatment for oral squamous cell carcinoma (OSCC), preserving oral function and appearance. Further research is needed to optimize PDT protocols for sustained success in managing this deadly cancer.
Area of Science:
- Oncology
- Biomedical Engineering
- Photomedicine
Background:
- Oral squamous cell carcinoma (OSCC) is a prevalent and lethal head and neck cancer.
- Conventional treatments like surgery and radiotherapy cause significant functional and cosmetic damage, impacting patient quality of life.
- Photodynamic therapy (PDT) presents a promising, less invasive alternative for OSCC management.
Purpose of the Study:
- To review the principles, mechanisms, and current applications of PDT for OSCC.
- To discuss challenges and innovations in PDT for OSCC treatment.
- To explore the role of biomarkers in refining PDT patient selection and treatment.
Main Methods:
- Literature review focusing on PDT principles, mechanisms, and applications in OSCC.
- Analysis of current challenges, including light penetration and hypoxia.
- Examination of advancements in photosensitizer technology, nanotechnology, and precision therapy.
Main Results:
- PDT demonstrates selective phototoxicity and necrosis in target tissues with minimal invasion and low side effects.
- Innovations are enhancing photosensitizers and integrating nanotechnology for improved PDT efficacy.
- Biomarker exploration aims to personalize PDT regimens for better patient outcomes.
Conclusions:
- PDT is a secure and effective modality for managing OSCC, preserving oral function and aesthetics.
- Addressing challenges like light penetration and hypoxia is crucial for optimizing PDT.
- Continued research and validation are essential to refine PDT protocols and ensure long-term therapeutic success in OSCC.
Related Concept Videos
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


